AU1706399A - Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation - Google Patents
Method for promoting hematopoietic and mesenchymal cell proliferation and differentiationInfo
- Publication number
- AU1706399A AU1706399A AU17063/99A AU1706399A AU1706399A AU 1706399 A AU1706399 A AU 1706399A AU 17063/99 A AU17063/99 A AU 17063/99A AU 1706399 A AU1706399 A AU 1706399A AU 1706399 A AU1706399 A AU 1706399A
- Authority
- AU
- Australia
- Prior art keywords
- differentiation
- cell proliferation
- mesenchymal cell
- promoting hematopoietic
- hematopoietic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000024245 cell differentiation Effects 0.000 title 1
- 230000003394 haemopoietic effect Effects 0.000 title 1
- 230000009681 mesenchymal cell proliferation Effects 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/32—Angiotensins [AT], angiotensinogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6659397P | 1997-11-26 | 1997-11-26 | |
US60066593 | 1997-11-26 | ||
PCT/US1998/025390 WO1999026644A1 (en) | 1997-11-26 | 1998-11-24 | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1706399A true AU1706399A (en) | 1999-06-15 |
Family
ID=22070492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU17063/99A Abandoned AU1706399A (en) | 1997-11-26 | 1998-11-24 | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1047441A1 (en) |
JP (1) | JP2002507383A (en) |
AU (1) | AU1706399A (en) |
CA (1) | CA2310852A1 (en) |
WO (1) | WO1999026644A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002509077A (en) | 1998-02-09 | 2002-03-26 | ユニヴァースティ オブ サザーン カリフォルニア | Erythropoiesis promotion method |
US6475988B1 (en) * | 1998-05-11 | 2002-11-05 | University Of Southern California | Methods to increase white blood cell survival after chemotherapy |
US6916783B2 (en) | 1998-07-13 | 2005-07-12 | University Of Southern California | Methods for accelerating bone and cartilage growth and repair |
US6258778B1 (en) | 1998-07-13 | 2001-07-10 | University Of Southern California | Methods for accelerating bone and cartilage growth and repair |
WO2000009144A1 (en) | 1998-08-13 | 2000-02-24 | University Of Southern California | Methods to increase blood flow to ischemic tissue |
US6730775B1 (en) | 1999-03-23 | 2004-05-04 | University Of Southern California | Methods for limiting scar and adhesion formation |
EP1218487A2 (en) * | 1999-09-23 | 2002-07-03 | Cell Science Therapeutics | Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
ATE372987T1 (en) | 2001-05-31 | 2007-09-15 | Vicore Pharma Ab | TRICYCLIC COMPOUNDS USEFUL AS ANGIOTENSIN II AGONISTS |
EP2455388A1 (en) | 2010-11-23 | 2012-05-23 | LanthioPep B.V. | Novel angiotensin type 2 (AT2) receptor agonists and uses thereof. |
US8557958B1 (en) | 2012-06-18 | 2013-10-15 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of diabetes |
US8633158B1 (en) | 2012-10-02 | 2014-01-21 | Tarix Pharmaceuticals Ltd. | Angiotensin in treating brain conditions |
CN103055301A (en) * | 2012-12-10 | 2013-04-24 | 南京医科大学 | Application of angiotensin II improving the ability of mesenchymal stem cells to repair myocardial ischemia injury |
US9333233B2 (en) | 2014-02-25 | 2016-05-10 | Tarix Pharmaceuticals Ltd. | Methods and compositions for the delayed treatment of stroke |
WO2016107879A2 (en) * | 2014-12-30 | 2016-07-07 | Vicore Pharma Ab | New use of angiotensin ii receptor agonists |
EP4007592A1 (en) | 2019-08-02 | 2022-06-08 | LanthioPep B.V. | Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5015629A (en) * | 1989-06-26 | 1991-05-14 | University Of Southern California | Tissue repair |
JPH09502977A (en) * | 1993-09-24 | 1997-03-25 | ザ ユニバーシティ オブ サザーン カリフォルニア | Use of Angiotensin III and its analogs in tissue repair |
US5834432A (en) * | 1995-06-06 | 1998-11-10 | The University Of Southern California | Use of angiotensin II Type 2 receptor agonists in tissue repair |
US6335195B1 (en) * | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
-
1998
- 1998-11-24 CA CA002310852A patent/CA2310852A1/en not_active Abandoned
- 1998-11-24 EP EP98961836A patent/EP1047441A1/en not_active Withdrawn
- 1998-11-24 AU AU17063/99A patent/AU1706399A/en not_active Abandoned
- 1998-11-24 WO PCT/US1998/025390 patent/WO1999026644A1/en not_active Application Discontinuation
- 1998-11-24 JP JP2000521846A patent/JP2002507383A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2310852A1 (en) | 1999-06-03 |
WO1999026644A1 (en) | 1999-06-03 |
JP2002507383A (en) | 2002-03-12 |
EP1047441A1 (en) | 2000-11-02 |
WO1999026644A9 (en) | 2000-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL130281A0 (en) | Serum-free cell culture media | |
AU2260097A (en) | Hematopoietic cell culture nutrient supplement | |
AU4330597A (en) | Serum-free mammalian cell culture medium, and uses thereof | |
AU9582398A (en) | Methods and devices for the long-term culture of hematopoietic progenitor cells | |
AU3152197A (en) | Improved porous biomaterials and methods for their manufacture | |
AU1706399A (en) | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation | |
AU5380898A (en) | In culture proliferation of human pancreatic endocrine cells | |
AU5116596A (en) | Cell culture method | |
AU6229498A (en) | Composition for gene introduction into cell | |
HUP0003012A3 (en) | Composition and method for regulating cell proliferation and cell death | |
AUPO229696A0 (en) | Analytic cell | |
AU3288497A (en) | Mammalian tolloid-like gene and protein | |
AU8827998A (en) | Porcine totipotent cells and method for long-term culture | |
AU7082694A (en) | Hematopoietic stem cell proliferation accelerator | |
AU5603298A (en) | Mammalian cytokine related to il10 | |
AU1685895A (en) | Hematopoietic cell expansion and transplantation methods | |
AUPO235996A0 (en) | Method of cell culture | |
AU1540197A (en) | Method and apparatus for culturing cells and tissues | |
GB9605453D0 (en) | Cultured cells | |
AU6726398A (en) | Nitrogen feed in statin fermentation | |
AU4311197A (en) | Culture system for hematopoietic stem cells | |
AU2133197A (en) | Apparatus and methods for culturing mammalian cells | |
GB2314332B (en) | Gene expression in mammalian cells | |
AU6054698A (en) | Adipocyte culture | |
AU5855598A (en) | Neuropeptides as modulators for cell differentiation and proliferation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |